Briefly, it has been shown that the degree of DNA methylation of melanoma cells facilitates the stratification of CM patients into four subgroups based on the expression of PD-L1 and TILs and that this information may provide clues about the therapeutic response and survival rates of these CM patients [190,191]. The gene discussed is CD274; the disease is melanoma.